Abstract
Ensemble-plus Study Design: An Investigation of Shortened Ocrelizumab Infusion Time on Infusion-related Reactions in Patients with Relapsing Multiple Sclerosis from the Phase Iiib Ensemble-plus Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have